期刊文献+

RNAi抑制胰腺癌PANC-1细胞MMP-2 mRNA的表达 被引量:1

Inhibitory effect of RNA interference on expression of MMP-2 mRNA in pancreatic carcinoma cell line PANC-1
原文传递
导出
摘要 目的观察RNAi体外沉默基质金属蛋白酶2(MMP-2)基因对胰腺癌PANC-1细胞MMP-2mRNA表达的抑制作用。方法设计靶向MMP-2的siRNA,并构建到pGCsi-U6质粒,重组质粒脂质体法转染PANC-1细胞;流式细胞术检测细胞GFP表达率,RQ-PCR检测细胞MMP-2的mRNA表达水平。结果 PCR鉴定证实重组质粒构建成功,质粒转染细胞GFP表达率最高达82.1%。转染干扰质粒的PANC-1细胞MMP-2基因mRNA表达抑制了71.74%(P<0.05)。结论 RNAi明显抑制胰腺癌PANC-1细胞MMP-2mRNA的表达,可望RNAi能为胰腺癌治疗开辟新的思路。 Objective To investigate the inhibitory effects of RNA interference(RNAi) on the expression of matrix metalloproteinase-2 (MMP-2) mRNA of human pancreatic carcinoma cell line PANC-1 in vitro.Methods Small interference RNA(siRNA) targeting MMP-2 gene was designed and constructed to plasmid pGCsi-U6.Recombinant plasmids were transfected to pancreatic carcinoma cell line PANC-1 cells with lipofectamine.Green fluorescence protein(GFP) was evaluated by flow cytometry after transfection.RQ-PCR was used to detect the expression of MMP-2 mRNA.ResultsPCR confirmed that the MMP-2 siRNA plasmid was successfully constructed.The best efficiency of GFP after transfection was 82.1% in PANC-1 cells.After transfected by the MMP-2 siRNA plasmid,the MMP-2 mRNA expression of PANC-1 cells was suppressed by 71.74%(P0.05).ConclusionRNAi targeting MMP-2 gene can obviously suppress the expression of MMP-2 mRNA of PANC-1 cells.RNAi is expected to open up a new approach to pancreatic carcinoma therapy.
出处 《江苏医药》 CAS CSCD 北大核心 2010年第16期1924-1927,共4页 Jiangsu Medical Journal
基金 卫生部科学研究基金(WKJ2004-2-011)
关键词 胰腺癌 基质金属蛋白酶2 RNA干扰 Pancreatic carcinoma Matrix metalloproteinase-2 RNA interference
  • 相关文献

参考文献4

二级参考文献38

  • 1孙亚男,李源,谢民强,金德均,姚鸿超,李鹏,李同丽.基质金属蛋白酶的表达与声门上喉癌淋巴结转移的关系[J].中华耳鼻咽喉科杂志,2004,39(11):692-694. 被引量:9
  • 2Elzbieta Skrzydlewska,Mariola Sulkowska,Mariusz Koda,Stanislaw Sulkowski.Proteolytic-antiproteolytic balance and its regulation in carcinogenesis[J].World Journal of Gastroenterology,2005,11(9):1251-1266. 被引量:15
  • 3蒋觉安,董万利,胡锦,王元元,惠国桢.抑制血管内皮生长因子表达的pSUPER-H1RNA干扰系统的构建[J].江苏医药,2006,32(4):333-336. 被引量:3
  • 4Laszlo Herszenyi,Istvan Hritz,Istvan Pregun,Ferenc Sipos,Mark Juhasz,Bela Molnar,Zsolt Tulassay.Alterations of glutathione S-transferase and matrix metalloproteinase-9 expressions are early events in esophageal carcinogenesis[J].World Journal of Gastroenterology,2007,13(5):676-682. 被引量:37
  • 5Gorogh T, Beier UH, Baumken J, et al. Metalloproteinases and their inhibitors: influence on tumor invasiveness and metastasis formation in head and neck squamous cell carcinomas. Head Neck, 2006, 28:31-39.
  • 6Bachmeier BE, Iancu CM, Jochum M, et al. Matrix metalloproteinases in cancer: comparison of known and novel aspects of their inhibition as a therapeutic approach. Expert Rev Anticancer Ther, 2005, 5:149-163.
  • 7Heath EI, Burtness BA, Kleinberg L, et al. Phase Ⅱ, paralleldesign study of preoperative combined modality therapy and the matrix metalloprotease ( mmp ) inhibitor prinomastat in patients with esophageal adenocarcinoma. Invest New Drugs, 2006, 24 : 135-140.
  • 8Mroz EA, Rocco JW. RNA interference: natural, experimental, and clinical roles in cancer biology. Head Neck, 2006, 28: 1132-1141.
  • 9Naldini L, Blamer U, Gallay P, et al. In vivo gene delivery and stable transduction of nondividing ceils by a lentiviral vector. Science, 1996, 272 (5259) : 263-267.
  • 10Xie M, Sun Y, Li Y. Expression of matrix metalloproteinases in supraglottic carcinoma and its clinical implication for estimating lymph node metastases. Laryngoscope, 2004, 114:2243-2248.

共引文献49

同被引文献8

引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部